Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients

• Status: Recruiting
• Trial end date: 2021-09-30
• Target enrollment: 0
• Participant gender: All

Summary

Chinese herbal medicine Jing si herbal tea can effectively reduce the expression of SARS CoV2 in the throat of infected patients, provide medical discoveries, formulate effective isolation policies of hospitals and homes, count the virus retention, develop effective medical care and protection of medical personnel, and create a win-win situation.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yao-Kuang Wu

Criteria

Inclusion Criteria:

• COVID infection patient and age over eighteen

Exclusion Criteria:

• severe pneumonia needing mechanical ventilation

• severe systemic diseases (i.e., malignancy, autoimmune diseases, liver or renal diseases)

• women during pregnancy or lactation

• participation in clinical trials within 3 months

• known allergies to the investigational medications

• other conditions judged by the investigators.